Wils L J, Poell J B, Evren I, Koopman M S, Brouns E R E A, de Visscher J G A M, Brakenhoff R H, Bloemena E
Ned Tijdschr Tandheelkd. 2021 Feb;128(2):103-111. doi: 10.5177/ntvt.2021.02.20078.
Oral leukoplakia is the most common potentially malignant disorder of the oral mucosa with a rate of malignant transformation into oral squamous cell carcinoma of 1-2% annually. The presence or absence of dysplasia as defined by the WHO is an important histological marker for malignant transformation risk assessment, but is not sufficiently accurate for patient stratification. We investigated whether identifying differentiated dysplasia contributes to oral leukoplakia malignant transformation risk assessment. We investigated whether classic or differentiated dysplasia were present in 84 oral leukoplakias. In 25 of these patients a squamous cell carcinoma developed during follow-up. Risk of malignant progression of oral leukoplakia increased from 3.3 (HR, p = 0.002) when only classic dysplasia was considered to 7.4 (HR, p = 0.001) when both classic and differentiated dysplasia were combined. This study demonstrates that identifying differentiated dysplasia as a separate type of dysplasia is important for the prognosis and stratification of patients with oral leukoplakia.
口腔白斑是口腔黏膜最常见的潜在恶性疾病,每年恶变为口腔鳞状细胞癌的发生率为1%-2%。世界卫生组织定义的发育异常的存在与否是评估恶性转化风险的重要组织学指标,但对于患者分层而言不够准确。我们研究了识别分化型发育异常是否有助于口腔白斑恶性转化风险评估。我们调查了84例口腔白斑中是否存在经典型或分化型发育异常。在这些患者中,有25例在随访期间发生了鳞状细胞癌。仅考虑经典型发育异常时,口腔白斑恶性进展风险为3.3(风险比,p = 0.002),而当经典型和分化型发育异常同时存在时,风险比增至7.4(风险比,p = 0.001)。本研究表明,将分化型发育异常识别为一种单独的发育异常类型对于口腔白斑患者的预后和分层很重要。